Search results
Allies of Donald Trump are pushing for the first nuclear tests in three decades
The Independent via Yahoo News· 10 hours agoThe Project 2025 proposals, written by Trump’s former defense secretary Christopher Miller, call for...
General Election 2024 London seat results: Who is my MP in...Putney?
Evening Standard via Yahoo News· 24 hours agoTory Justine Greening...was ousted. Ms Greening, who served in Cabinet in several roles including...
'My suspicion about my wife cheating was a sign of brain tumour'
Yahoo Life UK· 17 hours ago“We had a brain tumour staring us in the face the whole time and we didn’t pick up on it.” Louise...
Should Invesco S&P MidCap Value with Momentum ETF (XMVM) Be on Your Investing Radar?
Zacks via Yahoo News· 8 hours agoIWS has an expense ratio of 0.23% and VOE charges 0.07%. Bottom-Line While an excellent vehicle for...
Results of the IX Digital Asset Industry Classification System (“DAICS®”) 2024 1H Review - Media...
Sin Chew Daily· 24 hours agoHONG KONG SAR – Media OutReach Newswire – 5 July 2024 – Today, IX Asia Indexes announced the 1st Half 2024 Review of the IX Digital Asset Industry Classification System (“DAICS®“), aiming to provide the professionals wo...
Charles River (CRL) Could be an Apt Pick Right Now: Here's Why
Zacks via Yahoo News· 12 hours agoOverall, the RMS business is set to be a significant revenue growth driver in 2024. DSA Arm Thrives:...
Cancer deaths are down, so why does cancer scare us so much?
Washington Post via Yahoo News· 12 hours agoAnd now the bad: Cancer fear is not. In fact, experts say cancerphobia seems as strong as ever, even...
DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
Zacks via Yahoo News· 10 hours agoDexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and...
Here's Why You Need to Buy Realty Income (O) Stock Now
Zacks via Yahoo News· 12 hours agoA diversified tenant base, accretive buyouts and solid balance sheet strength bode well for Realty...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo News· 11 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...